Published in Oncogene on June 26, 2006
Cholangiocarcinoma. Lancet (2014) 4.52
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci U S A (2010) 4.17
Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev (2010) 3.77
Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet (2012) 3.63
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci U S A (2010) 3.18
Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci U S A (2008) 2.98
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42
Liver stem cells and hepatocellular carcinoma. Hepatology (2009) 2.27
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut (2013) 2.10
Cancer stem cells in the development of liver cancer. J Clin Invest (2013) 2.06
Human hepatic stem cell and maturational liver lineage biology. Hepatology (2011) 1.99
The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene (2009) 1.97
Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol (2010) 1.91
Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer. Cell (2015) 1.89
Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol (2009) 1.85
Alcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage. Alcohol Clin Exp Res (2010) 1.77
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology (2013) 1.76
The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol (2009) 1.67
Activation of stem cells in hepatic diseases. Cell Tissue Res (2007) 1.59
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies. Oncogene (2013) 1.55
Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol (2012) 1.55
The biliary tree--a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol (2012) 1.50
Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease. Nat Med (2011) 1.45
Novel therapeutic strategies for targeting liver cancer stem cells. Int J Biol Sci (2011) 1.39
Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer. Int J Clin Oncol (2008) 1.37
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World J Gastrointest Oncol (2010) 1.36
Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev (2008) 1.36
Wnt signaling in liver cancer. Curr Drug Targets (2008) 1.34
Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells (2009) 1.33
Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer (2009) 1.31
Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology (2008) 1.27
Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2. Gastroenterology (2010) 1.25
Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models. PLoS Genet (2011) 1.20
GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN. Oncogene (2013) 1.18
Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence. Am J Pathol (2009) 1.18
Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis. Hepatology (2014) 1.15
Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications. J Mol Med (Berl) (2008) 1.12
Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus. J Gastroenterol Hepatol (2012) 1.12
Cancer stem cells and hepatocellular carcinoma. Cancer Biol Ther (2009) 1.11
Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell Biosci (2011) 1.08
JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma. Mol Cancer (2009) 1.07
Prognostic factors for hepatocellular carcinoma recurrence. World J Gastroenterol (2014) 1.06
Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype. Int J Clin Exp Pathol (2013) 1.05
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. Cell (2014) 1.04
Stem cells in hepatocarcinogenesis: evidence from genomic data. Semin Liver Dis (2010) 1.02
Liver stem cells and tgf-Beta in hepatic carcinogenesis. Gastrointest Cancer Res (2008) 1.02
Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection. J Virol (2009) 1.00
Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology (2012) 0.98
The identification of stem cells in human liver diseases and hepatocellular carcinoma. Exp Mol Pathol (2010) 0.98
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment. J Clin Invest (2015) 0.95
Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro. Am J Pathol (2008) 0.95
Bmi1 is required for hepatic progenitor cell expansion and liver tumor development. PLoS One (2012) 0.93
Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity. World J Gastrointest Oncol (2012) 0.93
High expression of cancer stem cell markers in cholangiolocellular carcinoma. Surg Today (2012) 0.93
Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports. BMC Res Notes (2013) 0.91
Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice. Neoplasia (2014) 0.91
JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression? World J Gastroenterol (2007) 0.90
TLRs, Alcohol, HCV, and Tumorigenesis. Gastroenterol Res Pract (2011) 0.88
The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review). Int J Oncol (2014) 0.88
pIgR: frenemy of inflammation, EMT, and HCC progression. J Natl Cancer Inst (2011) 0.88
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (review). Int J Oncol (2014) 0.86
Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers. Liver Cancer (2013) 0.86
The GCTM-5 epitope associated with the mucin-like glycoprotein FCGBP marks progenitor cells in tissues of endodermal origin. Stem Cells (2012) 0.84
Cancer stem cells and therapeutic targets: an emerging field for cancer treatment. Drug Deliv Transl Res (2013) 0.84
Liver stem cells and molecular signaling pathways in hepatocellular carcinoma. Gastrointest Cancer Res (2007) 0.83
Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma. BMC Cancer (2014) 0.81
Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea. World J Gastroenterol (2015) 0.81
Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis. Cancer (2016) 0.80
Activation of canonical Wnt signaling pathway promotes proliferation and self-renewal of rat hepatic oval cell line WB-F344 in vitro. World J Gastroenterol (2008) 0.80
Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma. Med Mol Morphol (2012) 0.80
Effect of liver regeneration on malignant hepatic tumors. World J Gastroenterol (2014) 0.80
Role of liver stem cells in hepatocarcinogenesis. World J Stem Cells (2014) 0.79
Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinoma. PLoS One (2011) 0.79
Cancer stem cells in primary liver cancers: pathological concepts and imaging findings. Korean J Radiol (2015) 0.79
Expression of hepatocyte markers in mass-forming peripheral and periductal-infiltrating hilar intrahepatic cholangiocarcinomas. Oncol Lett (2011) 0.78
Activated hepatic stellate cells: negative regulators of hepatocyte proliferation in liver diseases. Hepatology (2012) 0.78
Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. World J Surg Oncol (2015) 0.78
Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells. Stem Cells Dev (2013) 0.78
The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma. Oncotarget (2017) 0.77
Adult Hepatic Progenitor Cell Niche: How it affects the Progenitor Cell Fate. Middle East J Dig Dis (2014) 0.77
Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma. Oncoscience (2015) 0.77
The CD133+CD44+ precancerous subpopulation of oval cells is a therapeutic target for hepatocellular carcinoma. Stem Cells Dev (2014) 0.77
Expression of the novel protein PTPIP51 in rat liver: an immunohistochemical study. Histochem Cell Biol (2007) 0.76
Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis. Immunity (2016) 0.76
Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis. Diagn Pathol (2017) 0.76
Apical membrane expression of distinct sulfated glycans represents a novel marker of cholangiolocellular carcinoma. Lab Invest (2016) 0.75
Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3'-methyl-4 dimethylaminoazobenzene in rats. J Toxicol Pathol (2015) 0.75
Signet-ring cell hilar cholangiocarcinoma: case report. Arq Bras Cir Dig (2015) 0.75
Environmental Ligands of the Aryl Hydrocarbon Receptor and Their Effects in Models of Adult Liver Progenitor Cells. Stem Cells Int (2016) 0.75
Hepatitis C virus infection of cholangiocarcinoma cell lines. J Gen Virol (2015) 0.75
Human ductal plate and its derivatives express antigens of cholangiocellular, hepatocellular, hepatic stellate/progenitor cell, stem cell, and neuroendocrine lineages, and proliferative antigens. Exp Biol Med (Maywood) (2016) 0.75
Progress in stem cell-derived technologies for hepatocellular carcinoma. Stem Cells Cloning (2010) 0.75
Biliary tract cancer stem cells - translational options and challenges. World J Gastroenterol (2017) 0.75
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease. World J Hepatol (2013) 0.75
Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE. Semin Intervent Radiol (2017) 0.75
Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma. Virchows Arch (2016) 0.75
Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. Redox Biol (2017) 0.75